Also listed on Theravance, Inc., an earlier holder on the record. The recorded assignments below show how it moved.
Term ended Oct 23, 2026 · Medium confidence
20-year base term ended Mar 10, 2025
Why Medium: A parent in the chain could not be resolved.
Held by Theravance Biopharma R&D IP, LLC
Filed Jan 5, 2022 as application 17/569,255 · Granted Mar 25, 2025
Base term plus 592 days of patent term adjustment (USPTO delay)
Today
Term ended Oct 23, 2026
2005
2026
Clock starts
Mar 10, 2005
Mar 10, 2005
Term ended
Oct 23, 2026
Oct 23, 2026
Granted
Mar 25, 2025
Mar 25, 2025
base term
patent term adjustment
after the term ends
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
592
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
None due
Maintenance fees
This term ends before the first maintenance fee's grace period does, 4 years from grant, so no fee can end it early.
16
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 592 days past its 20-year base term on prosecution delay. Confidence: Medium. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Mar 10, 2005, when application 11/077,433, the earliest non-provisional in its chain, was filed (this one was filed Jan 5, 2022); a parent in its chain could not be resolved (the next row) | Mar 10, 2025 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | +592 days, USPTO patent term adjustment record | Oct 23, 2026 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | No maintenance fee can end the term early | term ended | High confidence |
| Computed term end | The steps above, in order | Oct 23, 2026 | Medium confidence |
This family
| US 7,288,657 | In force Oct 2028 | Oct 2028 |
| US 8,017,783 | In force Jan 2028 | Jan 2028 |
| US 8,912,334 | Term ended Mar 2025 | Mar 2025 |
| US 12,258,316 | this patent Oct 2026 | Oct 2026 |
4 of 16 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Sep 24, 2026 Reel 76134, frame 790 | Theravance Biopharma R&D IP, LLC | U.S. Bank Trust Company, National Association | Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Note
The 592 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
5
later US patents cite this one
Fewer than half of the utility patents granted in 2025 in our data have been cited yet, so we show the count and do not rank on it.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.